Stay updated on Ertugliflozin in Hypertension & T2D Sympathetic Activity Clinical Trial
Sign up to get notified when there's something new on the Ertugliflozin in Hypertension & T2D Sympathetic Activity Clinical Trial page.

Latest updates to the Ertugliflozin in Hypertension & T2D Sympathetic Activity Clinical Trial page
- Check3 days agoNo Change Detected
- Check11 days agoChange DetectedRevision label updated from v3.5.2 to v3.5.3, indicating a minor page update or patch.SummaryDifference0.1%

- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedAdded revision label v3.5.2 and removed revision v3.5.0.SummaryDifference0.1%

- Check54 days agoChange DetectedSite revision updated from v3.4.3 to v3.5.0.SummaryDifference0.1%

- Check61 days agoChange Detected- Revision updated to v3.4.3; previous revision v3.4.2 was removed.SummaryDifference0.1%

- Check89 days agoChange DetectedAdded Revision: v3.4.2. Removed the funding-lapse notice that warned about potential delays in updates due to government funding; this is an administrative update and does not change the study details.SummaryDifference0.4%

- Check96 days agoChange DetectedAdded a government funding status notice to the page and updated the version from v3.4.0 to v3.4.1; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

Stay in the know with updates to Ertugliflozin in Hypertension & T2D Sympathetic Activity Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ertugliflozin in Hypertension & T2D Sympathetic Activity Clinical Trial page.